DJIA 17,658.86 -92.53 -0.52%
NASDAQ 5,078.02 -33.71 -0.66%
S&P 500 2,095.68 -12.89 -0.61%
market minute promo

Amgen, Inc. (NASDAQ: AMGN)

170.06 -1.41 (-0.82%)

REAL-TIME: Last trade at


company name or ticker

Recent Quotes

AMGN $169.86 -0.94%
Company Photos
(Click to zoom)
1D 1W 3M 6M 1Y 2Y 3Y
Today's Open $170.09
Previous Close $171.47
Daily Range $169.50 - $171.00
52-Week Range $124.76 - $174.80
Market Cap $129.3B
P/E Ratio 23.14
Dividend (Yield) $3.16 (1.8%)
Ex-Dividend Date
Dividend Pay Date
08/13/15
09/08/15
Volume 435,565
Average Daily Volume 3,331,974
Current FY EPS $9.61

Sector

Healthcare

Industry

Drug Makers

Amgen, Inc. (AMGN) Description

A biotechnology company which discovers, develops, manufactures and markets human therapeutics based on advances in cellular and molecular biology. Website: http://www.amgen.com/

News & Commentary Rss Feed

3 Questions to Ask Ahead of Amgen's Second-Quarter Earnings Release

The next big catalyst is right around the corner for Amgen. Find out what important questions you should be asking as Amgen readies to report its second-quarter earnings results on July 30.

Premarket Biotech Digest: Familial Hypercholesterolemia, Dynavax BLA Track, Earnings

Regeneron's Mega-Blockbuster Potential With Praluent: CVS Health Sees It, So Why Don't More Analysts

Regeneron's Mega-Blockbuster Potential With Praluent: CVS Health Sees It, So Why Don't More Analysts?

Earnings Scheduled For July 30, 2015

Biotech Stock Roundup: Biogen Down on Tecfidera Issues, Regeneron's Praluent Gets FDA Nod - Analyst

Biotech Stock Roundup: Biogen Down on Tecfidera Issues, Regeneron's Praluent Gets FDA Nod - Analyst Blog

3 Stocks Pushing The Drugs Industry Lower

Today's Market: Names Riding Momentum To All-Time Highs, Earnings To Focus On

Will Amgen (AMGN) Keep the Earnings Streak Alive in 2Q? - Analyst Blog

Merck Tops on Q2 Earnings & Revenues, Revises Outlook - Analyst Blog

Is More M&A On The Way For Large-Cap Biotechs?

NantKwest Inc.: Our IPO Pick Of The Week

See More AMGN News...

AMGN's Top Competitors

AMGN $170.06 (-0.82%)
Current stock: AMGN
GILD $115.70 (-0.01%)
Current stock: GILD
CELG $129.85 (-1.73%)
Current stock: CELG
$0.00 (0.00%)
Current stock: